Clinical Trial Update: Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating personalized escalation of consolidation therapy after chemoradiotherapy and immunotherapy in st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Maximilian Diehn | Conditions: Non Small Cell Lung Cancer, NSCLC, Stage III | Phase 3 | Status: RECRUITING